Shanghai Pharmaceuticals (601607.SH): Aliprazole tablets obtain drug registration certificate in the Philippines.

Wisdom Financial APP News, Shanghai Pharmaceuticals (601607.SH) announced that recently, the aripiprazole tablets produced by its subsidiary Shanghai Pharmaceutical Group Limited (referred to as "Shanghai Pharmaceuticals") have received a drug registration certificate issued by the Food and Drug Administration of the Philippines, and the drug has been approved for listing.